Literature DB >> 14515002

Is calcitonin an important physiological substance?

Philip F Hirsch1, Hans Baruch.   

Abstract

That calcitonin (CT) at supraphysiological doses is hypocalcemic led to the mistaken conclusion that it was important for calcium homeostasis and this idea has persisted to this day. Despite these findings, there is no readily apparent pathology due to CT excess or deficiency and there is no evidence that circulating CT is of substantial benefit to any mammal. Mammalian CT at physiological doses is not essential and very likely the CT gene has survived because of the gene's alternate mRNA pathway to produce calcitonin-gene-related peptide found in neural tissues. CT is not involved in calcium homeostasis or any other important physiological function, except, possibly, as an adjunct to protection of the skeleton under conditions of calcium stress, and appears to be in the process of becoming vestigial. CT produced in other tissues has paracrine actions that modulate functions such as proton transport, acid-base balance, prolactin secretion, and gastrointestinal motility. C-cells in mammals evolved from the ultimobranchial body that secretes CT in all lower vertebrates. It is highly probable that changes in amino acid sequence during evolution are responsible for the loss of activity, as fish CT is about 40 times as potent as human CT. CT may have been very important to survival in seawater fish, but the presence of the parathyroid gland and other evolutionary changes occurring in tetrapods suggest that the function of CT is no longer important.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14515002     DOI: 10.1385/ENDO:21:3:201

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.925


  53 in total

Review 1.  Evolutionary pathways of the calcitonin genes.

Authors:  C J Lips; P H Steenbergh; J W Höppener; R A Bovenberg; J van der Sluys Veer; H S Jansz
Journal:  Mol Cell Endocrinol       Date:  1988-05       Impact factor: 4.102

2.  Reduced bone mass in calcitonin-deficient rats whether lactating or not.

Authors:  P F Hirsch; J R Hagaman
Journal:  J Bone Miner Res       Date:  1986-04       Impact factor: 6.741

3.  [Study of the hypocalcemic mechanism of action of thyrocalcitonin].

Authors:  G Milhaud; A M Perault; M S Moukhtar
Journal:  C R Acad Hebd Seances Acad Sci D       Date:  1965-07-19

4.  Importance of endogenous thyrocalcitonin for protection against hypercalcemia in the rat.

Authors:  C W Cooper; P F Hirsch; P L Munson
Journal:  Endocrinology       Date:  1970-02       Impact factor: 4.736

5.  Calcium metabolism during lactation: enhanced effects of thyrocalcitonin.

Authors:  S U Toverud; C Harper; P L Munson
Journal:  Endocrinology       Date:  1976-08       Impact factor: 4.736

Review 6.  Calcitonin.

Authors:  P M Sexton; D M Findlay; T J Martin
Journal:  Curr Med Chem       Date:  1999-11       Impact factor: 4.530

7.  Axial and appendicular bone mineral density in patients with long-term deficiency or excess of calcitonin.

Authors:  D L Hurley; R D Tiegs; H W Wahner; H Heath
Journal:  N Engl J Med       Date:  1987-08-27       Impact factor: 91.245

8.  Regulation of extracellular calcium sensing in rat osteoclasts by femtomolar calcitonin concentrations.

Authors:  M Zaidi; V S Shankar; O A Adebanjo; F A Lai; M Pazianas; G Sunavala; A I Spielman; B R Rifkin
Journal:  Am J Physiol       Date:  1996-09

9.  Effect of elcatonin on experimental gastric and duodenal ulcers.

Authors:  H Ohno; M Noguchi; N Takayanagi
Journal:  Jpn J Pharmacol       Date:  1985-01

10.  Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma.

Authors:  N Barbot; C Calmettes; I Schuffenecker; J P Saint-André; B Franc; V Rohmer; P Jallet; J C Bigorgne
Journal:  J Clin Endocrinol Metab       Date:  1994-01       Impact factor: 5.958

View more
  9 in total

Review 1.  Salmon calcitonin: a review of current and future therapeutic indications.

Authors:  C H Chesnut; M Azria; S Silverman; M Engelhardt; M Olson; L Mindeholm
Journal:  Osteoporos Int       Date:  2007-12-11       Impact factor: 4.507

2.  Glucagon like peptide-1 receptor expression in the human thyroid gland.

Authors:  Belinda Gier; Peter C Butler; Chi K Lai; David Kirakossian; Matthew M DeNicola; Michael W Yeh
Journal:  J Clin Endocrinol Metab       Date:  2011-10-26       Impact factor: 5.958

3.  Procalcitonin and pneumonia: is it a useful marker?

Authors:  Mirjam Christ-Crain; Beat Müller
Journal:  Curr Infect Dis Rep       Date:  2007-05       Impact factor: 3.725

Review 4.  Thyroid safety in patients treated with liraglutide.

Authors:  M Gallo
Journal:  J Endocrinol Invest       Date:  2013-02       Impact factor: 4.256

Review 5.  Bone: incretin hormones perceiver or receiver?

Authors:  Ilaria Dicembrini; Edoardo Mannucci; Carlo Maria Rotella
Journal:  Exp Diabetes Res       Date:  2012-06-17

6.  Expression of Glucagon-Like Peptide 1 Receptor during Osteogenic Differentiation of Adipose-Derived Stem Cells.

Authors:  Yun Kyung Jeon; Min Jung Bae; Ju In Kim; Joo Hyoung Kim; Soo Jong Choi; Su Kyoung Kwon; Joon Hyop An; Sang Soo Kim; Bo Hyun Kim; Yong Ki Kim; In Joo Kim
Journal:  Endocrinol Metab (Seoul)       Date:  2014-07-02

Review 7.  Does salmon calcitonin cause cancer? A review and meta-analysis.

Authors:  G Wells; J Chernoff; J P Gilligan; D S Krause
Journal:  Osteoporos Int       Date:  2015-10-05       Impact factor: 4.507

8.  Calcitonin Response to Naturally Occurring Ionized Hypercalcemia in Cats with Chronic Kidney Disease.

Authors:  D H N van den Broek; R F Geddes; T L Williams; Y-M Chang; J Elliott; R E Jepson
Journal:  J Vet Intern Med       Date:  2018-02-22       Impact factor: 3.333

9.  The effects of calcitonin on the development of and Ca2+ levels in heat-shocked bovine preimplantation embryos in vitro.

Authors:  Shumpei Kamano; Shuntaro Ikeda; Miki Sugimoto; Shinichi Kume
Journal:  J Reprod Dev       Date:  2014-06-03       Impact factor: 2.214

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.